Proteomic analysis of alterations induced by perinatal hypoxic-ischemic brain injury

Journal of Proteome Research

Volumn 11, Issue 12, 2012, Pages 5794-5803

  Rosenkranz, Katja ^a   May, Caroline ^a   Meier, Carola ^b   Marcus, Katrin ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

2D DIGE; brain injury; hypoxia ischemia; mass spectrometry; proteomics

Indexed keywords

CALCINEURIN; CALCINEURIN A; CALPAIN; CORONIN 1A; GLIAL FIBRILLARY ACIDIC PROTEIN; KHELLIN; PHOSPHOPROTEIN DARPP 32; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; HEMISPHERE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEOMICS; RAT; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRAIN; CALCINEURIN; CALPAIN; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPOXIA-ISCHEMIA, BRAIN; MICROFILAMENT PROTEINS; PHOSPHORYLATION; PROTEOLYSIS; PROTEOME; PROTEOMICS; RATS; RATS, WISTAR; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

RATTUS;

EID: 84870898214     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3005869     Document Type: Article

References (80)

1. Volpe, J. J. Neurology of the newborn, 5 th ed.; Elsevier Health Sciences: Philadelphia, 2008; pp 1-1042.
2. Rosenkranz, K.; Meier, C. Umbilical cord blood cell transplantation after brain ischemia-From recovery of function to cellular mechanisms Ann Anat 2011, 193 (4) 371-9
3. Fan, X.; Kavelaars, A.; Heijnen, C. J.; Groenendaal, F.; van Bel, F. Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury Curr. Neuropharmacol. 2010, 8 (4) 324-34
4. Volpe, J. J. Perinatal brain injury: from pathogenesis to neuroprotection Ment. Retard. Dev. Disabil. Res. Rev. 2001, 7 (1) 56-64
5. Vannucci, S. J.; Hagberg, H. Hypoxia-ischemia in the immature brain J. Exp. Biol. 2004, 207 (Pt 18) 3149-54
6. Liao, Y.; Cotten, M.; Tan, S.; Kurtzberg, J.; Cairo, M. S. Rescuing the neonatal brain from hypoxic injury with autologous cord blood Bone Marrow Transplant 2012, 10.1038/bmt.2012.169
7. Bennet, L.; Tan, S.; Van den Heuij, L.; Derrick, M.; Groenendaal, F.; van Bel, F.; Juul, S.; Back, S. A.; Northington, F.; Robertson, N. J.; Mallard, C.; Gunn, A. J. Cell therapy for neonatal hypoxia-ischemia and cerebral palsy Ann. Neurol. 2012, 71 (5) 589-600
8. Thornton, C.; Rousset, C. I.; Kichev, A.; Miyakuni, Y.; Vontell, R.; Baburamani, A. A.; Fleiss, B.; Gressens, P.; Hagberg, H. Molecular mechanisms of neonatal brain injury Neurol. Res. Int. 2012, 10.1155/2012/506320
9. Hu, X.; Rea, H. C.; Wiktorowicz, J. E.; Perez-Polo, J. R. Proteomic analysis of hypoxia/ischemia-induced alteration of cortical development and dopamine neurotransmission in neonatal rat J. Proteome Res. 2006, 5 (9) 2396-404
10. Levine, S. Anoxic-ischemic encephalopathy in rats Am. J. Pathol. 1960, 36, 1-17
11. Rice, J. E., 3rd; Vannucci, R. C.; Brierley, J. B. The influence of immaturity on hypoxic-ischemic brain damage in the rat Ann. Neurol. 1981, 9 (2) 131-41
12. Rosenkranz, K.; Kumbruch, S.; Lebermann, K.; Marschner, K.; Jensen, A.; Dermietzel, R.; Meier, C. The chemokine SDF-1/CXCL12 contributes to the "homing" of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain J. Neurosci. Res. 2010, 88 (6) 1223-1233
13. Bona, E.; Aden, U.; Gilland, E.; Fredholm, B. B.; Hagberg, H. Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists Neuropharmacology 1997, 36 (9) 1327-38
14. May, C.; Brosseron, F.; Chartowski, P.; Meyer, H. E.; Marcus, K. Differential Proteome Analysis Using 2D-DIGE Methods Mol. Biol. 2012, 893, 75-82
15. May, C.; Brosseron, F.; Pfeiffer, K.; Meyer, H. E.; Marcus, K. Proteome Analysis with Classical 2D-PAGE Methods Mol. Biol. 2012, 893, 37-46
16. Klose, J.; Kobalz, U. Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome Electrophoresis 1995, 16 (6) 1034-59
17. Kurz, A.; May, C.; Schmidt, O.; Muller, T.; Stephan, C.; Meyer, H. E.; Gispert, S.; Auburger, G.; Marcus, K. A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP. J. Neural Transm. 2012, 119 (3), 297-312.
18. Reidegeld, K. A.; Eisenacher, M.; Kohl, M.; Chamrad, D.; Korting, G.; Bluggel, M.; Meyer, H. E.; Stephan, C. An easy-to-use Decoy Database Builder software tool, implementing different decoy strategies for false discovery rate calculation in automated MS/MS protein identifications Proteomics 2008, 8 (6) 1129-37
19. Rosenkranz, K.; Kumbruch, S.; Tenbusch, M.; Marcus, K.; Marschner, K.; Dermietzel, R.; Meier, C. Transplantation of human umbilical cord blood cells mediated beneficial effects on apoptosis, angiogenesis and neuronal survival after hypoxic-ischemic brain injury in rats Cell Tissue Res. 2012, 348 (3) 429-438
20. Vannucci, R. C.; Towfighi, J.; Vannucci, S. J. Secondary energy failure after cerebral hypoxia-ischemia in the immature rat J. Cereb. Blood Flow Metab. 2004, 24 (10) 1090-7
21. Meier, C.; Middelanis, J.; Wasielewski, B.; Neuhoff, S.; Roth-Haerer, A.; Gantert, M.; Dinse, H. R.; Dermietzel, R.; Jensen, A. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells Pediatr. Res. 2006, 59 (2) 244-9
22. Bona, E.; Johansson, B. B.; Hagberg, H. Sensorimotor function and neuropathology five to six weeks after hypoxia-ischemia in seven-day-old rats Pediatr. Res. 1997, 42 (5) 678-83
23. Pimentel-Coelho, P. M.; Magalhaes, E. S.; Lopes, L. M.; Deazevedo, L. C.; Santiago, M. F.; Mendez-Otero, R. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum Stem Cells Dev. 2010, 19 (3) 351-8
24. Hossain, M. A.; Russell, J. C.; O'Brien, R.; Laterra, J. Neuronal pentraxin 1: a novel mediator of hypoxic-ischemic injury in neonatal brain J. Neurosci. 2004, 24 (17) 4187-96
25. Petrak, J.; Ivanek, R.; Toman, O.; Cmejla, R.; Cmejlova, J.; Vyoral, D.; Zivny, J.; Vulpe, C. D. Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins Proteomics 2008, 8 (9) 1744-9
26. Zabel, C.; Andreew, A.; Mao, L.; Hartl, D. Protein expression overlap: more important than which proteins change in expression? Expert Rev. Proteomics 2008, 5 (2) 187-205
27. Ahmed, Z.; Shaw, G.; Sharma, V. P.; Yang, C.; McGowan, E.; Dickson, D. W. Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry J. Histochem. Cytochem. 2007, 55 (7) 687-700
28. Shioda, N.; Moriguchi, S.; Shirasaki, Y.; Fukunaga, K. Generation of constitutively active calcineurin by calpain contributes to delayed neuronal death following mouse brain ischemia J. Neurochem. 2006, 98 (1) 310-20
29. Lakshmikuttyamma, A.; Selvakumar, P.; Sharma, A. R.; Anderson, D. H.; Sharma, R. K. In vitro proteolytic degradation of bovine brain calcineurin by m-calpain Neurochem. Res. 2004, 29 (10) 1913-21
30. Lankiewicz, S.; Marc Luetjens, C.; Truc Bui, N.; Krohn, A. J.; Poppe, M.; Cole, G. M.; Saido, T. C.; Prehn, J. H. Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death J. Biol. Chem. 2000, 275 (22) 17064-71
31. Bevers, M. B.; Neumar, R. W. Mechanistic role of calpains in postischemic neurodegeneration J. Cereb. Blood Flow Metab. 2008, 28 (4) 655-73
32. Siman, R.; Baudry, M.; Lynch, G. Brain fodrin: substrate for calpain I, an endogenous calcium-activated protease Proc. Natl. Acad. Sci. U. S. A. 1984, 81 (11) 3572-6
33. Nishi, A.; Snyder, G. L.; Greengard, P. Bidirectional regulation of DARPP-32 phosphorylation by dopamine J. Neurosci. 1997, 17 (21) 8147-55
34. King, M. M.; Huang, C. Y.; Chock, P. B.; Nairn, A. C.; Hemmings, H. C., Jr.; Chan, K. F.; Greengard, P. Mammalian brain phosphoproteins as substrates for calcineurin J. Biol. Chem. 1984, 259 (13) 8080-3
35. Greengard, P. The neurobiology of dopamine signaling Biosci. Rep. 2001, 21 (3) 247-69
36. Wishcamper, C. A.; Brooks, D. M.; Douglas Coffin, J.; Lurie, D. I. Focal cerebral ischemia upregulates SHP-1 in reactive astrocytes in juvenile mice Brain Res. 2003, 974 (1-2) 88-98
37. Bonifacio, S. L.; Glass, H. C.; Peloquin, S.; Ferriero, D. M. A new neurological focus in neonatal intensive care Nat. Rev. Neurol. 2011, 7 (9) 485-94
38. Marlow, N.; Rose, A. S.; Rands, C. E.; Draper, E. S. Neuropsychological and educational problems at school age associated with neonatal encephalopathy Arch. Dis. Child. Fetal Neonat. Ed. 2005, 90 (5) F380-7
39. Edwards, A. D.; Brocklehurst, P.; Gunn, A. J.; Halliday, H.; Juszczak, E.; Levene, M.; Strohm, B.; Thoresen, M.; Whitelaw, A.; Azzopardi, D. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data BMJ 2010, 340, c363
40. Volpe, J. J. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances Lancet Neurol. 2009, 8 (1) 110-24
41. Shankaran, S.; Laptook, A. R.; Ehrenkranz, R. A.; Tyson, J. E.; McDonald, S. A.; Donovan, E. F.; Fanaroff, A. A.; Poole, W. K.; Wright, L. L.; Higgins, R. D.; Finer, N. N.; Carlo, W. A.; Duara, S.; Oh, W.; Cotten, C. M.; Stevenson, D. K.; Stoll, B. J.; Lemons, J. A.; Guillet, R.; Jobe, A. H. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy N. Engl. J. Med. 2005, 353 (15) 1574-84
42. Gluckman, P. D.; Gunn, A. J.; Wyatt, J. S. Hypothermia for neonates with hypoxic-ischemic encephalopathy. N. Engl. J. Med. 2006, 354 (15), 1643-5; author reply 1643-5.
43. Jacobs, S.; Hunt, R.; Tarnow-Mordi, W.; Inder, T.; Davis, P. Cooling for newborns with hypoxic ischaemic encephalopathy Cochrane Database Syst. Rev. 2007, 4) CD003311
44. Azzopardi, D.; Brocklehurst, P.; Edwards, D.; Halliday, H.; Levene, M.; Thoresen, M.; Whitelaw, A. The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial BMC Pediatr. 2008, 8, 17
45. Dirnagl, U.; Iadecola, C.; Moskowitz, M. A. Pathobiology of ischaemic stroke: an integrated view Trends Neurosci. 1999, 22 (9) 391-7
46. Ivacko, J. A.; Sun, R.; Silverstein, F. S. Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats Pediatr. Res. 1996, 39 (1) 39-47
47. Ohno, M.; Aotani, H.; Shimada, M. Glial responses to hypoxic/ischemic encephalopathy in neonatal rat cerebrum Brain Res. Dev. Brain Res. 1995, 84 (2) 294-8
48. Volpe, J. J. Neonatal encephalopathy: an inadequate term for hypoxic-ischemic encephalopathy Ann. Neurol. 2012, 72 (2) 156-66
49. Humphries, C. L.; Balcer, H. I.; D'Agostino, J. L.; Winsor, B.; Drubin, D. G.; Barnes, G.; Andrews, B. J.; Goode, B. L. Direct regulation of Arp2/3 complex activity and function by the actin binding protein coronin J. Cell Biol. 2002, 159 (6) 993-1004
50. Amantea, D.; Nappi, G.; Bernardi, G.; Bagetta, G.; Corasaniti, M. T. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators FEBS J. 2009, 276 (1) 13-26
51. Arvin, B.; Neville, L. F.; Barone, F. C.; Feuerstein, G. Z. The role of inflammation and cytokines in brain injury Neurosci. Biobehav. Rev. 1996, 20 (3) 445-52
52. Streit, W. J.; Walter, S. A.; Pennell, N. A. Reactive microgliosis Prog. Neurobiol. 1999, 57 (6) 563-81
53. Feinstein, D. L.; Weinmaster, G. A.; Milner, R. J. Isolation of cDNA clones encoding rat glial fibrillary acidic protein: expression in astrocytes and in Schwann cells J. Neurosci. Res. 1992, 32 (1) 1-14
54. Alvarez-Diaz, A.; Hilario, E.; de Cerio, F. G.; Valls-i-Soler, A.; Alvarez-Diaz, F. J. Hypoxic-ischemic injury in the immature brain-key vascular and cellular players Neonatology 2007, 92 (4) 227-35
55. Pekny, M.; Nilsson, M. Astrocyte activation and reactive gliosis Glia 2005, 50 (4) 427-34
56. Yiu, G.; He, Z. Glial inhibition of CNS axon regeneration Nat. Rev. Neurosci. 2006, 7 (8) 617-27
57. Rodnight, R.; Goncalves, C. A.; Wofchuk, S. T.; Leal, R. Control of the phosphorylation of the astrocyte marker glial fibrillary acidic protein (GFAP) in the immature rat hippocampus by glutamate and calcium ions: possible key factor in astrocytic plasticity Braz. J. Med. Biol. Res. 1997, 30 (3) 325-38
58. Vinade, L.; Goncalves, C. A.; Wofchuk, S.; Gottfried, C.; Rodnight, R. Evidence for a role for calcium ions in the dephosphorylation of glial fibrillary acidic protein (GFAP) in immature hippocampal slices and in astrocyte cultures from the rat Brain Res. Dev. Brain Res. 1997, 104 (1-2) 11-7
59. Wasielewski, B.; Jensen, A.; Roth-Harer, A.; Dermietzel, R.; Meier, C. Neuroglial activation and Cx43 expression are reduced upon transplantation of human umbilical cord blood cells after perinatal hypoxic-ischemic injury Brain Res. 2012, 1487, 39-53
60. Horvat, A.; Schwaiger, F.; Hager, G.; Brocker, F.; Streif, R.; Knyazev, P.; Ullrich, A.; Kreutzberg, G. W. A novel role for protein tyrosine phosphatase shp1 in controlling glial activation in the normal and injured nervous system J. Neurosci. 2001, 21 (3) 865-74
61. Winder, D. G.; Sweatt, J. D. Roles of serine/threonine phosphatases in hippocampal synaptic plasticity Nat. Rev. Neurosci. 2001, 2 (7) 461-74
62. Zeng, H.; Chattarji, S.; Barbarosie, M.; Rondi-Reig, L.; Philpot, B. D.; Miyakawa, T.; Bear, M. F.; Tonegawa, S. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory Cell 2001, 107 (5) 617-29
63. Yakel, J. L. Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription Trends Pharmacol. Sci. 1997, 18 (4) 124-34
64. Tanaka, C.; Nishizuka, Y. The protein kinase C family for neuronal signaling Annu. Rev. Neurosci. 1994, 17, 551-67
65. Schreiber, S. S.; Baudry, M. Selective neuronal vulnerability in the hippocampus-a role for gene expression? Trends Neurosci. 1995, 18 (10) 446-51
66. Choi, D. W. Excitotoxic cell death J. Neurobiol. 1992, 23 (9) 1261-76
67. Hong, S. C.; Lanzino, G.; Goto, Y.; Kang, S. K.; Schottler, F.; Kassell, N. F.; Lee, K. S. Calcium-activated proteolysis in rat neocortex induced by transient focal ischemia Brain Res. 1994, 661 (1-2) 43-50
68. Croall, D. E.; DeMartino, G. N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation Physiol. Rev. 1991, 71 (3) 813-47
69. Shioda, N.; Han, F.; Moriguchi, S.; Fukunaga, K. Constitutively active calcineurin mediates delayed neuronal death through Fas-ligand expression via activation of NFAT and FKHR transcriptional activities in mouse brain ischemia J. Neurochem. 2007, 102 (5) 1506-17
70. Morioka, M.; Hamada, J.; Ushio, Y.; Miyamoto, E. Potential role of calcineurin for brain ischemia and traumatic injury Prog. Neurobiol. 1999, 58 (1) 1-30
71. Kaminska, B.; Gaweda-Walerych, K.; Zawadzka, M. Molecular mechanisms of neuroprotective action of immunosuppressants-facts and hypotheses J. Cell Mol. Med. 2004, 8 (1) 45-58
72. Liu, J.; Farmer, J. D., Jr.; Lane, W. S.; Friedman, J.; Weissman, I.; Schreiber, S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes Cell 1991, 66 (4) 807-15
73. Uchino, H.; Minamikawa-Tachino, R.; Kristian, T.; Perkins, G.; Narazaki, M.; Siesjo, B. K.; Shibasaki, F. Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition Neurobiol. Dis. 2002, 10 (3) 219-33
74. Vanags, D. M.; Porn-Ares, M. I.; Coppola, S.; Burgess, D. H.; Orrenius, S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis J. Biol. Chem. 1996, 271 (49) 31075-85
75. Blomgren, K.; Zhu, C.; Wang, X.; Karlsson, J. O.; Leverin, A. L.; Bahr, B. A.; Mallard, C.; Hagberg, H. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J. Biol. Chem. 2001, 276 (13) 10191-8
76. Bevers, M. B.; Ingleton, L. P.; Che, D.; Cole, J. T.; Li, L.; Da, T.; Kopil, C. M.; Cohen, A. S.; Neumar, R. W. RNAi targeting micro-calpain increases neuron survival and preserves hippocampal function after global brain ischemia Exp. Neurol. 2010, 224 (1) 170-7
77. Hemmings, H. C., Jr.; Nairn, A. C.; Aswad, D. W.; Greengard, P. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus J. Neurosci. 1984, 4 (1) 99-110
78. Jones, P. B.; Rantakallio, P.; Hartikainen, A. L.; Isohanni, M.; Sipila, P. Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort Am. J. Psychiatry 1998, 155 (3) 355-64
79. Cannon, M.; Jones, P. B.; Murray, R. M. Obstetric complications and schizophrenia: historical and meta-analytic review Am. J. Psychiatry 2002, 159 (7) 1080-92
80. Zornberg, G. L.; Buka, S. L.; Tsuang, M. T. Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study Am. J. Psychiatry 2000, 157 (2) 196-202